The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Biopharmaceutical benchmarks 2022
Open accessAbstract
Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Self-citationBiopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978
Self-citationBiopharmaceutical benchmarks 2010
Walsh, G. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-917 · Cited by 756
Self-citationmRNA vaccine: a potential therapeutic strategy
Wang, Y., Zhang, Z., Luo, J., Han, X., Wei, Y., & Wei, X. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01311-z · Cited by 422
Biopharmaceutical benchmarks 2006
Walsh, G. (2006) · Nature Biotechnology · doi:10.1038/nbt0706-769 · Cited by 359
Self-citationSARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Bettini, E., & Locci, M. (2021) · Vaccines · doi:10.3390/vaccines9020147 · Cited by 279
Targeting cancer with antibody-drug conjugates: Promises and challenges
Dean, A. Q., Luo, S., Twomey, J. D., & Zhang, B. (2021) · mAbs · doi:10.1080/19420862.2021.1951427 · Cited by 190
Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
Cagigi, A., & Loré, K. (2021) · Vaccines · doi:10.3390/vaccines9010061 · Cited by 153
Kelley, B. D., Kiss, R., & Laird, M. W. (2018) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2018_59 · Cited by 50
Cited by
Roberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Vaskó, D., Pantea, E., Domján, J., Fehér, C., Mózner, O., Sarkadi, B., Nagy, Z. K., Marosi, G. J., & Hirsch, E. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124251 · Cited by 12
From cell clones to recombinant protein product heterogeneity in Chinese hamster ovary cell systems
Wang, C., Guo, X., Wang, W., Li, J.-X., & Wang, T.-Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031324 · Cited by 9
A Hybrid Modeling Framework for Predictive Digital Twins of CHO Cell Culture
Richelle, A., Andersson, D., Antonakoudis, A., Jakobsson, J., Pijeaud, S., Vernersson, A., & Trygg, J. (2025) · doi:10.1101/2025.11.24.690194 · Cited by 6
Bravo-Venegas, J., Rodriguez-Siza, J., Vergara, M., Torres, M., Dickson, A., Toledo, J. R., Molina, M. C., Hermoso, M. A., Berríos, J., & Altamirano, C. (2026) · mAbs · doi:10.1080/19420862.2026.2643039 · Cited by 6
“5 Despite their successes, industrial mAb development is has challenges, with glycosylation as a significant area.”
Metadata
- Authors
- Walsh, G., & Walsh, E.
- Venue
- Nature Biotechnology
- Published
- 2022-12
- Volume
- 40
- Issue
- 12
- Pages
- 1722-1760
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W4311675123
- Cited by
- 552
- References
- 11
- FWCI
- 78.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biopharmaceutical benchmarks 2022. https://app.cochat.ai/papers/10.1038/s41587-022-01582-x
- The paper
- Walsh, G., & Walsh, E. (2022). Biopharmaceutical benchmarks 2022. Nature Biotechnology. https://doi.org/10.1038/s41587-022-01582-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.